相关产品推荐更多 >

G Protein Coupled Receptor 161 (GPR161) Antibody (Biotin)/G Protein Coupled Receptor 161 (GPR161) Antibody (Biotin)/G Protein Coupled Receptor 161 (GPR161) Antibody (Biotin)
询价
ELSPBP1 抗体-ELSPBP1 Antibody
¥22
METTL2 抗体-METTL2 Antibody
¥22
Chromosome 15 Open Reading Frame 41 (C15ORF41) Antibody (HRP)/Chromosome 15 Open Reading Frame 41 (C15ORF41) Antibody (HRP)/Chromosome 15 Open Reading Frame 41 (C15ORF41) Antibody (HRP)
询价
氨基酸转运蛋白A1 抗体:偶联ATTO 700|SNAT1 Antibody: ATTO 700
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
A synthetic peptide corresponding to a sequence within amino acids 50 to the C-terminus of human EIF4EBP1 (NP_004086.1).
- 保存条件:
Store at -20℃
- 保质期:
1年
- 级别:
科研级别
- 库存:
100
- 供应商:
艾美捷科技
- 宿主:
兔
- 应用范围:
WB,IHC,IF
- 抗体英文名:
EIF4EBP1 Antibody, KO Validated
- 抗体名:
EIF4EBP1 Antibody, KO Validated
- 规格:
50uL
EIF4EBP1 抗体, KO Validated,EIF4EBP1 Antibody, KO Validated,EIF4EBP1 抗体, KO Validated,EIF4EBP1 Antibody, KO Validated
产品名称:EIF4EBP1 抗体, KO Validated-EIF4EBP1 Antibody, KO Validated
产品货号:PSI-14-450-50uL
产品规格:50uL
背景资料:This gene encodes one member of a family of translation repressor proteins. The protein directly interacts with eukaryotic translation initiation factor 4E (eIF4E), which is a limiting component of the multisubunit complex that recruits 40S ribosomal subunits to the 5' end of mRNAs. Interaction of this protein with eIF4E inhibits complex assembly and represses translation. This protein is phosphorylated in response to various signals including UV irradiation and insulin signaling, resulting in its dissociation from eIF4E and activation of mRNA translation.
保存建议:EIF4EBP1 抗体, KO Validated-EIF4EBP1 Antibody, KO ValidatedStore at -20℃
应用类型:WB,IHC,IF
点击:EIF4EBP1 抗体, KO Validated-EIF4EBP1 Antibody, KO Validated查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论,请点击查看艾美捷特色产品中心。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Methods 2016 年的文章2,国际抗体验证工作小组(International Working Group on Antibody Validation, IWGAV)提出 5 种支柱策略(conceptual pillar),如下:1. 基因策略(敲除验证):利用 CRISPR/Cas 或 RNAi 等技术对靶基因进行敲除(knock out)或敲低(knock down),分别检测对照组与 KO 组的信号。2. 正交策略:在多种样品中使用一种与抗体无关的定量方法,然后比较分析基于抗体的定量
双特异抗体(Bispecific antibody)的简介和制作方法
、双特异抗体简介双特异抗体(Bispecific antibody)是含有两个不同配体结合位点的免疫球蛋白分子。自然状态下不存在双特异性抗体,只能通过特殊方法进行制备。以往双特异抗体的制备方法有化学交联法,杂合F(ab')2 分子法和鼠杂交瘤法等。化学交联法生产双特异抗体的异源性,批与批之间的不稳定性,以及抗体特异性易受某些修饰或不当连接而改变的特性,使得该法生产的双特异抗体不适于体内使用。以巯基交联蛋白酶消化片断F(ab')生产的双特异杂交分子,成分虽较均一,但费时费力,且产量很低。杂交瘤法生产
Improving Phage Display Throughput by Using Hyperphage, Miniaturized Titration and pVIII (g8p) ELISA
Hyperphage is a substitute for M13KO7 helper phage used in antibody phage display. It allows to improve the antibody display efficiency on phage by 2-3 orders of magnitude. This is achieved by forcing the packaging E. coli cell to exclusively
技术资料暂无技术资料 索取技术资料






